📈 Business
·
CNBC
·
AstraZeneca Shares Jump 4% After Surprise Win in Lung Disease Trial
AstraZeneca shares jumped 4% on Friday after the company announced a surprise clinical trial win for an experimental chronic obstructive pulmonary disease (COPD) drug. The drug reduced flare-ups in patients where rival treatments had previously failed. The result marks a significant breakthrough in a competitive therapeutic area.
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.